Trial Profile
A Clinical Trial Comparing the Performance of the JACTAX LD DES With the TAXUS Liberte DES.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Sponsors Boston Scientific Corporation; Labcoat
- 05 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 05 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Oct 2008 New trial record.